Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18816698

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2009 Feb
First author
Griffin TC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Pediatr Blood Cancer. 2009 Feb;52(2):150-2. doi: 10.1002/pbc.21857.
    note
    Source null
    related pmid
    19034905
    relationship
    Comment in

Authors and identifiers

  1. name
    Griffin TC
    type
    Author
  2. name
    Weitzman S
    type
    Author
  3. name
    Weinstein H
    type
    Author
  4. name
    Chang M
    type
    Author
  5. name
    Cairo M
    type
    Author
  6. name
    Hutchison R
    type
    Author
  7. name
    Shiramizu B
    type
    Author
  8. name
    Wiley J
    type
    Author
  9. name
    Woods D
    type
    Author
  10. name
    Barnich M
    type
    Author
  11. name
    Gross TG
    type
    Author
  12. name
    Children's Oncology Group
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Griffin TC
    type
    Author
  2. name
    Weitzman S
    type
    Author
  3. name
    Weinstein H
    type
    Author
  4. name
    Chang M
    type
    Author
  5. name
    Cairo M
    type
    Author
  6. name
    Hutchison R
    type
    Author
  7. name
    Shiramizu B
    type
    Author
  8. name
    Wiley J
    type
    Author
  9. name
    Woods D
    type
    Author
  10. name
    Barnich M
    type
    Author
  11. name
    Gross TG
    type
    Author
  12. name
    Children's Oncology Group
    type
    CollectiveName
bibliography ids
  1. nci-bib-7f1a67ce4cc86739dbb022a3
book metadata
content sha256
63a051e0a4ce47257800a4037ecfeaec5992425a6e6071890473a155926a2cc8
document type
citation
dois
  1. 10.1002/pbc.21753
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:18816698
immutable id
pubmed:18816698@63a051e0a4ce47257800a4037ecfeaec5992425a6e6071890473a155926a2cc8
journal
abbreviation
Pediatr Blood Cancer
issn electronic
1545-5017
issn print
1545-5009
issue
2
name
Pediatric blood & cancer
nlm unique id
101186624
pages
177-81
volume
52
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Pediatr Blood Cancer. 2009 Feb;52(2):150-2. doi: 10.1002/pbc.21857.
    note
    Source null
    related pmid
    19034905
    relationship
    Comment in
outcomes validated
false
pmid
18816698
provenance
batch id
6281e3e555c9a831cffc
provider
NCBI PubMed ESummary
record sha256
55056b526343f13796ea97ecb515c0e01f4418dbe487235742e64a5339dcbb30
response sha256
0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
retrieved at
2026-09-09T23:46:21.772457+00:00
publication date
display
2009 Feb
precision
month
year
2009
publication types
  1. Clinical Trial
  2. Journal Article
  3. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18816698/
title
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Preserved source evidence · Not medical advice